Rare diseases
Investigational molecules
Locations
290 conditions with trials, the busiest first
1 641 trials across Europe, recruiting first
Study of felzartamab compared to placebo in adults with IgA nephropathy
BelgiumStudy of GHZ339 for treatment of moderate to severe atopic dermatitis
CzechiaStudy of sublingual immunotherapy with Dermatophagoides pteronyssinus and Dermatophagoides farinae allergen mix for patients with dust mite allergic rhinitis
SpainStudy of Ritlecitinib Combined with Narrow Band UVB Light Therapy Compared to Ritlecitinib Alone in Adults with Vitiligo
FranceStudy of Colchicine to Reduce Complications in People with Type 1 Diabetes and High Blood Sugar Variability
The NetherlandsStudy of IMMUNOSTEM gene therapy using modified stem cells for newly diagnosed patients with type 1 diabetes who still produce insulin
ItalyStudy of MTX-463 compared to placebo to assess its safety and effectiveness in adults with idiopathic pulmonary fibrosis
BelgiumStudy of cardiovascular disease prevention using carotid ultrasound in patients with inflammatory rheumatic diseases treated with amlodipine, atorvastatin, rosuvastatin, ezetimibe and bempedoic acid
SpainStudy of efgartigimod given by IV infusion in adolescents aged 12-17 years with chronic immune thrombocytopenia
FranceStudy of inhaled aprotinin for treatment of moderate to severe acute respiratory distress syndrome
SpainStudy of Mezagitamab in Adults with Primary IgA Nephropathy (Berger's Disease) to Reduce Protein in Urine
AustriaStudy of Janus kinase inhibitor dose reduction in patients with rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis who have achieved low disease activity
The NetherlandsThe therapies tested most often in Immune system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
